Healthcare -
Biotechnology - NASDAQ - US
$ 0.36
-0.0278 %
$ 1.75 M
Market Cap
-0.01
P/E
PBLA - OPERATING EXPENSES
Operating Expenses PBLA - Panbela Therapeutics, Inc.
25.6 M
LAST VALUE
60.07%
2 YEAR CAGR
46.22%
5 YEAR CAGR
45.34%
10 YEAR CAGR